Cato T Laurencin

This inventor holds 29 USPTO granted patents and 18 published patent applications, plus 4 CIPO patents and 2 EPO patents, primarily in Tissue Engineering. Top assignees: Massachusetts Institute of Technology, University of Connecticut, Drexel University. Active years: 1989-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cato T Laurencin. Retrieved from https://idiyas.com/inventor/cato-t-laurencin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 18)

% Patents Active = 82.8

CIPO Patents = 4

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 3.4

ph-index = 12

Forward Citations = 945(Granted Patents)

Location History:

Cambridge, MA (US) (1989)
Philadelphia, PA (US) (1992 - 2001)
Somerville, MA (US) (1994 - 2001)
Earlysville, VA (US) (2007 - 2013)
Elkins Park, PA (US) (2004 - 2015)
Avon, CT (US) (2013 - 2022)
Farmington, CT (US) (2015 - 2024)

Company Filing History:

8 out of 8,586

Massachusetts Institute of Technology

patents

8 out of 784

University of Connecticut

Soft Tissue Regeneration, Inc.

patents

5. 2 out of 1,044

University of Virginia Patent Foundation

Carnegie Mellon University

patents

8. 1 out of 408

Cytec Technology Corporation

University of Pennsylvania

patents

11. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2024

Loading Chart...

Areas of Expertise:

Graphene-Based Nanofibers

Tissue Regeneration

Biocompatible Scaffolds

Controlled Release

Polymeric Composites

Nanofiber Scaffolds

Bone Repair

Ligament Replacement

Drug Delivery Systems

Hydroxamic Acid Polymers

Gradient Scaffolds

Mechanical Competence

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12102730 - Graphene-based nanofibers for skeletal muscle tissue regeneration (2024-10-01),

2. 12091522 - Graphene composite matrices and uses thereof (2024-09-17),

3. 11946030 - Multi-chamber cell culture system (2024-04-02),

4. 11479617 - Chelator-functionalized glycosaminoglycans (2022-10-25),

5. 10307514 - Gradient porous scaffolds (2019-06-04),

6. 10179039 - Bi-phasic 3-dimenisonal nanofiber scaffolds, two parallel beam collector device and methods of use (2019-01-15),

7. 9757132 - Mechanically competent scaffold for rotator cuff and tendon augmentation (2017-09-12),

8. 9707322 - Gradient porous scaffolds (2017-07-18),

9. 9433489 - Absorbable synthetic braided matrix for breast reconstruction and hernia repair (2016-09-06),

10. 8945218 - Ligament and tendon replacement constructs and methods for production and use thereof (2015-02-03),

11. 8927018 - Immobilized metallic nanoparticles as unique materials for therapeutic and biosensor applications (2015-01-06),

12. 8758437 - Mechanically competent scaffold for ligament and tendon regeneration (2014-06-24),

13. 8614189 - Carbon nanotube composite scaffolds for bone tissue engineering (2013-12-24),

14. 8536230 - Methods for regulating gelation of polysaccharide solutions and uses thereof (2013-09-17),

15. 8486143 - Mechanically competent scaffold for ligament and tendon regeneration (2013-07-16),

Title: The Innovative Journey of Cato T. Laurencin

Introduction: Cato T. Laurencin, a distinguished inventor hailing from Avon, CT (US), is renowned for his groundbreaking contributions to the field of regenerative engineering.

Latest Patents: Cato T. Laurencin holds several patents in the field of regenerative medicine, including innovative techniques for tissue engineering and biomaterials.

Career Highlights: Dr. Laurencin's illustrious career includes serving as a professor at the University of Connecticut and as the CEO of the Connecticut Convergence Institute for Translation in Regenerative Engineering. He has received numerous awards for his pioneering work.

Collaborations: Throughout his career, Cato T. Laurencin has collaborated with leading researchers, universities, and companies worldwide to advance the field of regenerative engineering and bring innovative solutions to healthcare.

Conclusion: Cato T. Laurencin's dedication to innovation and his groundbreaking work in regenerative engineering have solidified his legacy as a visionary inventor shaping the future of healthcare.

Profile summary based on public USPTO records.